Hemophilia treatment and transfusion medicine
10.13303/j.cjbt.issn.1004-549x.2025.02.002
- VernacularTitle:血友病治疗与输血医学
- Author:
Yunhai FANG
1
;
Yan CHENG
1
;
Xinsheng ZHANG
1
Author Information
1. Shandong Blood Center, Shandong Hemophilia Treatment Center, Jinan 250014, China
- Publication Type:Journal Article
- Keywords:
hemophilia;
transfusion medicine;
virus inactivation;
individualized treatment
- From:
Chinese Journal of Blood Transfusion
2025;38(2):168-171
- CountryChina
- Language:Chinese
-
Abstract:
The improvement of hemophilia treatment is attributed to the development of transfusion medicine, and the discovery of cryoprecipitate has opened up a new era of hemophilia treatment, laying the foundation for the development of modern hemophilia therapies. But with the further improvement of hemophilia treatment and the emergence of new treatment methods, transfusion medicine no longer plays a dominant role in hemophilia treatment. The new technologies and methods for hemophilia treatment can provide reference for the development of transfusion medicine, thereby better serving clinical practice and patients.
